Tirzepatide
TR20 20 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
Survodutide
SUR10 10 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
Semaglutide
SEMA20 20 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
Retatrutide
RT20 20 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
Mazdutide
MZ10 10 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
Liraglutide
LIRA30 30 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
Dulaglutide
DUL10 10 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
Cagrilintide
CGL5 10 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
cagrilintide 5mg+ Semaglutide5mg
CS5 5mg10 vials
Component identity, ratio and total content confirmed against the signed blend specificationPrice on Request
Add to Quote
CagriSema
CAGSM5 5 mg
Component identity, ratio and total content confirmed against the signed blend specificationPrice on Request
Add to Quote